Biodiversity Medicine: New Horizon and New Opportunity for Cancer.
Cancer Discov
; 14(3): 392-395, 2024 Mar 01.
Article
en En
| MEDLINE
| ID: mdl-38426557
ABSTRACT
SUMMARY:
Accessibility to standard of care remains a challenge to patients in low- and middle-income countries (LMIC), hampering efforts to alleviate the burden of cancer and to improve overall health outcomes. In response to this pressing global health care issue, we propose here a new strategy to create affordable, easily accessible, and effective therapeutic solutions to address this inequity in cancer treatment the use of science-based biodiversity medicine as an alternative to modern drug therapy, in which we will leverage and combine high-throughput omics technologies with artificial intelligence, to study local biodiversity, their potential anticancer properties, and short- and long-term clinical response and outcomes.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Países en Desarrollo
/
Neoplasias
Límite:
Humans
Idioma:
En
Revista:
Cancer Discov
Año:
2024
Tipo del documento:
Article
País de afiliación:
Singapur